VTP50469 fumarate is the fumarate salt of VTP50469, a potent, highly selective, orally active inhibitor of the Menin-MLL (MLL1) protein-protein interaction. It has a reported Ki of 104 pM and demonstrates potent anti-leukemia activity in preclinical studies. The compound is supplied for research use with supporting datasheet, certificate of analysis, and safety data.
- Highly potent inhibitor with a reported Ki of 104 pM.
- Orally active compound effective in preclinical leukemia models.
- Selective mode of action targeting the Menin-MLL interaction.
- High purity suitable for biochemical and cellular studies.
- Supplied with datasheet, COA, and SDS for lab use.
- Available in small research quantities for preclinical experiments.